Milestone Scientific Inc. MLSS NYSE

Milestone Scientific Inc. (MLSS) generated $-226.13K in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $12.01K, free cash flow was $-214.12K.

Free cash flow margin was -10.4% of revenue. Cash conversion ratio was 0.21x, suggesting some earnings are non-cash.

Criteria supported by this page:

• HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (50/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (10/100) — Cash conversion ratio was 0.21x suggests some earnings are non-cash items

Overall SharesGrow Score: 56/100 with 3/7 criteria passed.